
Research ArticleDual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options
Keywords: پاسخ پایدار ویروسی; HCV; hepatitis C virus; DAA; direct-acting antiviral; PegIFN-α/RBV; peginterferon alfa and ribavirin; SVR; sustained virologic response; HIV; human immunodeficiency virus; NS5A; non-structural protein 5A; NS3; non-structural protein 3; ALT; alanine amino